SELE and prostate cancer: Several E-selectin ligands have been identified on human colon cancer, prostate cancer, leukemic, and hematopoietic cells, such as CD43, PSGL-1, CD44, PCLP, and CEA [2], [4], [16], [17], [18], [19], [20].